{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:03:19Z","timestamp":1792623799631,"version":"4.5.0"},"reference-count":236,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Matrix metalloproteinases (MMPs) are a family of enzymes that play an important role in the pathophysiology of hypertensive disorders, particularly through their involvement in extracellular matrix (ECM) remodeling and vascular dysfunction. Their activity is closely linked to hypertension-mediated organ damage, which affects the vascular and cardio-renal systems. MMPs are responsible for degrading various components of the ECM, which is crucial for maintaining vascular structure and function. In hypertensive patients, several MMPs, including MMP-1, MMP-3, and MMP-9, are often found at elevated levels. This is associated with vascular remodeling and dysfunction due to chronic high blood pressure. The activation of MMPs in hypertension can be triggered by several factors, such as oxidative stress, inflammatory cytokines, and vasoactive agents like angiotensin II. In addition to increasing MMP activity, these variables cause an imbalance between MMPs and tissue inhibitors of metalloproteinases (TIMPs), which are the MMPs\u2019 natural inhibitors. This imbalance contributes to excessive degradation of the ECM and promotes pathological changes in vascular smooth muscle cells (VSMCs), leading to their transition from a contractile to a synthetic phenotype. This shift facilitates cell growth and migration, exacerbating vascular remodeling. Given their critical roles in hypertension-related organ damage, MMPs are being explored as potential pharmacological targets. Inhibitors of MMPs may help mitigate the adverse effects of hypertension by restoring balance in ECM remodeling processes. Understanding their mechanisms opens avenues for targeted therapies that could significantly improve outcomes for individuals suffering from hypertension-related complications.<\/jats:p>","DOI":"10.3389\/fphar.2025.1559288","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T10:05:12Z","timestamp":1748253912000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Metalloproteinases (MMPs) in hypertensive disorders: role, function, pharmacology, and potential strategies to mitigate pathophysiological changes"],"prefix":"10.3389","volume":"16","author":[{"given":"Soroush","family":"Taherkhani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Sheibani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mohammadkhanizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitka A. I.","family":"Virag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisandra","family":"de Castro Braz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaser","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/B978-0-12-813006-3.00004-0","article-title":"Polyphenolic flavonoids and metalloprotease inhibition: applications to health and disease","volume-title":"Polyphenols: mechanisms of action in human health and disease","author":"Agi\u0107","year":"2018"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1161\/CIRCULATIONAHA.105.573865","article-title":"Matrix metalloproteinases\/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease","volume":"113","author":"Ahmed","year":"2006","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.matbio.2020.04.005","article-title":"Targeting the renin-angiotensin-aldosterone system in fibrosis","volume":"91","author":"AlQudah","year":"2020","journal-title":"Matrix Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.2174\/1568026611208011149","article-title":"The role of matrix metalloproteinases in essential hypertension","volume":"12","author":"Androulakis","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"18454","DOI":"10.3390\/ijms160818454","article-title":"Novel electrocardiographic patterns for the prediction of hypertensive disorders of pregnancy\u2014from pathophysiology to practical implications","volume":"16","author":"Angeli","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/s0167-4889(01)00187-2","article-title":"Green tea polyphenol (\u2212)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells","volume":"1542","author":"Annabi","year":"2002","journal-title":"Biochimica Biophysica Acta (BBA)-Molecular Cell Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.atherosclerosis.2005.07.004","article-title":"Cardiac isoform of alpha-2 macroglobulin\u2014a new biomarker for myocardial infarcted diabetic patients","volume":"186","author":"Annapoorani","year":"2006","journal-title":"Atherosclerosis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/bcpt.12282","article-title":"Matrix metalloproteinases are involved in cardiovascular diseases","volume":"115","author":"Azevedo","year":"2014","journal-title":"Basic & Clin. Pharmacol. & Toxicol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/eurheartj\/ehi073","article-title":"Neurohormonal activation is associated with increased levels of plasma matrix metalloproteinase-2 in human heart failure","volume":"26","author":"Banfi","year":"2005","journal-title":"Eur. heart J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1096\/fj.12-221598","article-title":"Activated \u03b12\u2010macroglobulin induces M\u00fcller glial cell migration by regulating MT1\u2010MMP activity through LRP1","volume":"27","author":"Barcelona","year":"2013","journal-title":"FASEB J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1093\/cvr\/cvx115","article-title":"Matrix metalloproteinase-2 knockout prevents angiotensin II-induced vascular injury","volume":"113","author":"Barhoumi","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.4155\/fmc.09.83","article-title":"Biochemical insights into the role of matrix metalloproteinases in regeneration: challenges and recent developments","volume":"1","author":"Bellayr","year":"2009","journal-title":"Future Med. Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000441621","article-title":"Matrix metalloproteinase 2 as a potential mediator of vascular smooth muscle cell migration and chronic vascular remodeling in hypertension","volume":"52","author":"Belo","year":"2016","journal-title":"J. Vasc. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1161\/01.HYP.0000145180.38707.84","article-title":"Pathophysiology of hypertensive renal damage: implications for therapy","volume":"44","author":"Bidani","year":"2004","journal-title":"Hypertension"},{"key":"B15","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.yjmcc.2009.08.024","article-title":"The extracellular matrix: at the center of it all","volume":"48","author":"Bowers","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/2050312119843700","article-title":"Hypertension in pregnancy: pathophysiology and treatment","volume":"7","author":"Braunthal","year":"2019","journal-title":"SAGE Open Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e138332","DOI":"10.1172\/JCI138332","article-title":"The matrix metalloproteinase inhibitor IPR-179 has antiseizure and antiepileptogenic effects","volume":"131","author":"Broekaart","year":"2021","journal-title":"J. Clin. investigation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/antiox10050749","article-title":"Implications of oxidative and nitrosative post-translational modifications in therapeutic strategies against reperfusion damage","volume":"10","author":"Buelna-Chontal","year":"2021","journal-title":"Antioxidants"},{"key":"B19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1023\/a:1023889805133","article-title":"The role of the matrix metalloproteinases during in vitro vessel formation","volume":"5","author":"Burbridge","year":"2002","journal-title":"Angiogenesis"},{"key":"B20","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/978-3-319-15961-4_31","article-title":"Pathophysiology of Hypertension","volume-title":"Pathophysiology and Pharmacotherapy of Cardiovascular Disease","author":"Burnier","year":"2015"},{"key":"B21","doi-asserted-by":"publisher","first-page":"9739","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/jcb.22737","article-title":"Activated \u03b12 macroglobulin induces matrix metalloproteinase 9 expression by low\u2010density lipoprotein receptor\u2010related protein 1 through MAPK\u2010ERK1\/2 and NF\u2010\u03baB activation in macrophage\u2010derived cell lines","volume":"111","author":"C\u00e1ceres","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3390\/molecules21091147","article-title":"Red grape skin polyphenols blunt matrix metalloproteinase-2 and-9 activity and expression in cell models of vascular inflammation: protective role in degenerative and inflammatory diseases","volume":"21","author":"Calabriso","year":"2016","journal-title":"Molecules"},{"key":"B24","doi-asserted-by":"publisher","first-page":"14847","DOI":"10.3390\/ijms241914847","article-title":"The effect of gene editing by CRISPR-Cas9 of miR-21 and the indirect target MMP9 in metastatic prostate cancer","volume":"24","author":"Camargo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B25","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/B978-0-12-374530-9.00020-6","article-title":"Pathophysiology of primary hypertension","volume-title":"Microcirculation","author":"Carey","year":"2008"},{"key":"B26","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.phrs.2011.04.002","article-title":"Matrix metalloproteinases: targets for doxycycline to prevent the vascular alterations of hypertension","volume":"64","author":"Castro","year":"2011","journal-title":"Pharmacol. Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"F905","DOI":"10.1152\/ajprenal.00421.2006","article-title":"Role of matrix metalloproteinases in renal pathophysiologies","volume":"292","author":"Catania","year":"2007","journal-title":"Am. J. Physiology-Renal Physiology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3109\/10409238.2010.501783","article-title":"Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases","volume":"45","author":"Cauwe","year":"2010","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/10409230701340019","article-title":"The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases","volume":"42","author":"Cauwe","year":"2007","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"120932","DOI":"10.1016\/j.lfs.2022.120932","article-title":"Flavonoids as regulators of TIMPs expression in cancer: consequences, opportunities, and challenges","volume":"308","author":"Cayetano-Salazar","year":"2022","journal-title":"Life Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"14093","DOI":"10.1096\/fj.202001701R","article-title":"Catecholamines in the regulation of angiogenesis in cutaneous wound healing","volume":"34","author":"Chakroborty","year":"2020","journal-title":"FASEB J. official Publ. Fed. Am. Soc. Exp. Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1158\/0008-5472.CAN-08-4289","article-title":"Catecholamines regulate tumor angiogenesis","volume":"69","author":"Chakroborty","year":"2009","journal-title":"Cancer Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/jcb.22363","article-title":"Role of matrix metalloproteinases in epithelial migration","volume":"108","author":"Chen","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"928315","DOI":"10.1155\/2013\/928315","article-title":"Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling","volume":"2013","author":"Chen","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jvs.2004.08.035","article-title":"Matrix metalloproteinase-specific inhibition of Ca2+ entry mechanisms of vascular contraction","volume":"40","author":"Chew","year":"2004","journal-title":"J. Vasc. Surg."},{"key":"B36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ijcard.2016.11.204","article-title":"Treatment of cardiovascular pathology with epigenetically active agents: focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation","volume":"227","author":"Chistiakov","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jff.2018.05.001","article-title":"Chemopreventive effects of polyphenol-rich extracts against cancer invasiveness and metastasis by inhibition of type IV collagenases expression and activity","volume":"46","author":"Chojnacka","year":"2018","journal-title":"J. Funct. Foods"},{"key":"B38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/sj.bjp.0707344","article-title":"Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature","volume":"152","author":"Chow","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"6894","DOI":"10.3390\/ijms23136894","article-title":"Matrix metalloproteinases and their inhibitors in pulmonary fibrosis: EMMPRIN\/CD147 comes into play","volume":"23","author":"Chuli\u00e1-Peris","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.copbio.2013.04.011","article-title":"Extracellular matrix signaling in morphogenesis and repair","volume":"24","author":"Clause","year":"2013","journal-title":"Curr. Opin. Biotechnol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1055\/s-0043-104775","article-title":"Correlating in vitro target-oriented screening and docking: inhibition of matrix metalloproteinases activities by flavonoids","volume":"83","author":"Crasc\u00ec","year":"2017","journal-title":"Planta Medica"},{"key":"B42","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1080\/10408398.2016.1229657","article-title":"Natural antioxidant polyphenols on inflammation management: anti-glycation activity vs metalloproteinases inhibition","volume":"58","author":"Crasc\u00ec","year":"2018","journal-title":"Crit. Rev. food Sci. Nutr."},{"key":"B43","doi-asserted-by":"publisher","first-page":"637148","DOI":"10.3389\/fgene.2021.637148","article-title":"Epigenetic regulation of the N-terminal truncated isoform of matrix metalloproteinase-2 (NTT-MMP-2) and its presence in renal and cardiac diseases","volume":"12","author":"Cruz","year":"2021","journal-title":"Front. Genet."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.02.005","article-title":"Biochemical and biological attributes of matrix metalloproteinases","volume":"147","author":"Cui","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/ph14010031","article-title":"The pharmacological TAILS of matrix metalloproteinases and their inhibitors","volume":"14","author":"Das","year":"2020","journal-title":"Pharmaceuticals"},{"key":"B46","doi-asserted-by":"publisher","first-page":"113623","DOI":"10.1016\/j.ejmech.2021.113623","article-title":"Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies","volume":"223","author":"Das","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"B47","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1124\/pharmrev.121.000349","article-title":"Matrix metalloproteinases: from molecular mechanisms to physiology, pathophysiology, and pharmacology","volume":"74","author":"de Almeida","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"B48","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.thromres.2024.01.001","article-title":"High alpha-2-macroglobulin levels are a risk factor for cardiovascular disease events: a Moli-sani cohort study","volume":"234","author":"de Laat-Kremers","year":"2024","journal-title":"Thrombosis Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/nrendo.2014.44","article-title":"The pathophysiology of hypertension in patients with obesity","volume":"10","author":"DeMarco","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e11256","DOI":"10.1371\/journal.pone.0011256","article-title":"Broad-spectrum matrix metalloproteinase inhibition curbs inflammation and liver injury but aggravates experimental liver fibrosis in mice","volume":"5","author":"de Meijer","year":"2010","journal-title":"PloS one"},{"key":"B51","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.vph.2018.10.002","article-title":"Matrix metalloproteinase (MMP)-2 activation by oxidative stress decreases aortic calponin-1 levels during hypertrophic remodeling in early hypertension","volume":"116","author":"de Mello","year":"2019","journal-title":"Vasc. Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/15376510601077003","article-title":"Effect of ellagic acid, a plant polyphenol, on fibrotic markers (MMPs and TIMPs) during alcohol-induced hepatotoxicity","volume":"17","author":"Devipriya","year":"2007","journal-title":"Toxicol. Mech. Methods"},{"key":"B53","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1097\/01.hjh.0000226182.60321.69","article-title":"Role of the renin\u2013angiotensin\u2013aldosterone system in vascular remodeling and inflammation: a clinical review","volume":"24","author":"Duprez","year":"2006","journal-title":"J. Hypertens."},{"key":"B54","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/biomimetics8020146","article-title":"The extracellular matrix: its composition, function, remodeling, and role in tumorigenesis","volume":"8","author":"Dzobo","year":"2023","journal-title":"Biomimetics"},{"key":"B55","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10554-010-9704-2","article-title":"Midregional pro-atrial natriuretic peptide: a novel marker of myocardial fibrosis in patients with hypertrophic cardiomyopathy","volume":"27","author":"Elmas","year":"2011","journal-title":"Int. J. Cardiovasc. imaging"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1055\/s-2004-832630","article-title":"Inhibition of matrix metalloproteinase-2 and-9 activities by selected flavonoids","volume":"70","author":"Ende","year":"2004","journal-title":"Planta Medica"},{"key":"B57","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.amjhyper.2004.06.025","article-title":"Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients","volume":"17","author":"Ergul","year":"2004","journal-title":"Am. J. Hypertens."},{"key":"B58","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.cardfail.2012.04.002","article-title":"Changes in plasma profiles of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in stress-induced cardiomyopathy","volume":"18","author":"Essa","year":"2012","journal-title":"J. cardiac Fail."},{"key":"B59","doi-asserted-by":"publisher","first-page":"124-e1","DOI":"10.1016\/j.ajog.2017.10.226","article-title":"Maternal hemodynamics: a method to classify hypertensive disorders of pregnancy","volume":"218","author":"Ferrazzi","year":"2018","journal-title":"Am. J. obstetrics Gynecol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/17460441.2020.1819235","article-title":"Challenges with matrix metalloproteinase inhibition and future drug discovery avenues","volume":"16","author":"Fischer","year":"2021","journal-title":"Expert Opin. drug Discov."},{"key":"B61","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cca.2011.12.021","article-title":"Circulating matrix metalloproteinases and their inhibitors in hypertension","volume":"413","author":"Fontana","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"B62","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3109\/10641960802668730","article-title":"Matrix metalloproteinases: discrete elevations in essential hypertension and hypertensive end-stage renal disease","volume":"31","author":"Friese","year":"2009","journal-title":"Clin. Exp. Hypertens."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1093\/ndt\/gfv048","article-title":"Emerging role of post-translational modifications in chronic kidney disease and cardiovascular disease","volume":"30","author":"Gajjala","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"B64","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1161\/res.90.3.251","article-title":"Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly","volume":"90","author":"Galis","year":"2002","journal-title":"Circulation Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3390\/jcm9020472","article-title":"Matrix metalloproteinases in diabetic kidney disease","volume":"9","author":"Garcia-Fernandez","year":"2020","journal-title":"J. Clin. Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ab.2005.04.038","article-title":"Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities","volume":"344","author":"Gerlach","year":"2005","journal-title":"Anal. Biochem."},{"key":"B67","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.placenta.2016.04.020","article-title":"Stillbirth, hypertensive disorders of pregnancy, and placental pathology","volume":"43","author":"Gibbins","year":"2016","journal-title":"Placenta"},{"key":"B68","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.drudis.2019.07.013","article-title":"Understanding the variability of the S1\u2032 pocket to improve matrix metalloproteinase inhibitor selectivity profiles","volume":"25","author":"Gimeno","year":"2020","journal-title":"Drug Discov. Today"},{"key":"B69","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1158\/1078-0432.CCR-04-2144","article-title":"Phase I trial of the matrix metalloproteinase inhibitor marimastat combined with carboplatin and paclitaxel in patients with advanced non\u2013small cell lung cancer","volume":"11","author":"Goffin","year":"2005","journal-title":"Clin. cancer Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/bs.pmbts.2017.01.002","article-title":"Matrix metalloproteinases and platelet function","volume":"147","author":"Gresele","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3390\/ijms21041203","article-title":"Early programming of adult systemic essential hypertension","volume":"21","author":"Guarner-Lans","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"23","DOI":"10.59249\/KFYZ8002","article-title":"Integrated analysis of tracheobronchial fluid from before and after cardiopulmonary bypass reveals activation of the integrated stress response and altered pulmonary microvascular permeability","volume":"96","author":"Habet","year":"2023","journal-title":"Yale J. Biol. Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.yexmp.2015.01.006","article-title":"The importance of extracellular matrix for cell function and in vivo likeness","volume":"98","author":"Hansen","year":"2015","journal-title":"Exp. Mol. pathology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1161\/CIRCRESAHA.121.318082","article-title":"Pathophysiology of hypertension: the mosaic theory and beyond","volume":"128","author":"Harrison","year":"2021","journal-title":"Circulation Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13578-020-00451-x","article-title":"Epigenetic regulation of matrix metalloproteinases in inflammatory diseases: a narrative review","volume":"10","author":"He","year":"2020","journal-title":"Cell & Biosci."},{"key":"B76","first-page":"127","article-title":"Matrix metalloproteinases: their biological functions and clinical implications","volume":"106","author":"Hijova","year":"2005","journal-title":"Bratisl. Lek. Listy"},{"key":"B77","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.3390\/nu12123651","article-title":"The protective effects of flavonoids in cataract formation through the activation of Nrf2 and the inhibition of MMP-9","volume":"12","author":"Hilliard","year":"2020","journal-title":"Nutrients"},{"key":"B79","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jvs.2006.09.066","article-title":"Matrix metalloproteinases in peripheral vascular disease","volume":"45","author":"Hobeika","year":"2007","journal-title":"J. Vasc. Surg."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1080\/14767058.2020.1776251","article-title":"Immediate postpartum management of patients with severe hypertensive disorders of pregnancy: pathophysiology guiding practice","volume":"35","author":"Hogg","year":"2022","journal-title":"J. Maternal-Fetal & Neonatal Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nrd2308","article-title":"Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases","volume":"6","author":"Hu","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.3791\/2445","article-title":"Detection of functional matrix metalloproteinases by zymography","author":"Hu","year":"2010","journal-title":"J. Vis. Exp. JoVE"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.3390\/molecules22122172","article-title":"Extraction optimization of flavonoids from Hypericum formosanum and matrix metalloproteinase-1 inhibitory activity","volume":"22","author":"Huang","year":"2017","journal-title":"Molecules"},{"key":"B84","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1046\/j.1538-7836.2003.00019.x","article-title":"Serum concentration of alpha1-proteinase inhibitor and alpha2-macroglobulin correlates with late lumen loss following coronary stent implantation","volume":"1","author":"Ikari","year":"2003","journal-title":"J. Thrombosis Haemostasis"},{"key":"B85","doi-asserted-by":"publisher","first-page":"578","DOI":"10.5551\/jat.3590","article-title":"Advanced glycation end product-mediated matrix metallo-proteinase-9 and apoptosis via renin-angiotensin system in type 2 diabetes","volume":"17","author":"Ishibashi","year":"2010","journal-title":"J. Atheroscler. thrombosis"},{"key":"B86","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3390\/biomedicines12040794","article-title":"Natural products as regulators against matrix metalloproteinases for the treatment of cancer","volume":"12","author":"Islam","year":"2024","journal-title":"Biomedicines"},{"key":"B87","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/14756366.2016.1161620","article-title":"Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs","volume":"31","author":"Jab\u0142o\u0144ska-Trypu\u0107","year":"2016","journal-title":"J. enzyme inhibition Med. Chem."},{"key":"B88","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/s0369-8114(01)00151-1","article-title":"Extracellular matrix remodeling in the vascular wall","volume":"49","author":"Jacob","year":"2001","journal-title":"Pathol. Biol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1161\/ATVBAHA.111.225623","article-title":"Matrix metalloproteinase (MMP)-3 activates MMP-9 mediated vascular smooth muscle cell migration and neointima formation in mice","volume":"31","author":"Johnson","year":"2011","journal-title":"Arteriosclerosis, thrombosis, Vasc. Biol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10989-016-9525-9","article-title":"Insight into the anti-inflammatory mechanism of action of atrial natriuretic peptide, a heart derived peptide hormone: involvement of COX-2, MMPs, and NF-kB pathways","volume":"22","author":"Kalaiarasu","year":"2016","journal-title":"Int. J. Peptide Res. Ther."},{"key":"B91","doi-asserted-by":"publisher","first-page":"39105","DOI":"10.1074\/jbc.M403627200","article-title":"A theoretical model of type I collagen proteolysis by matrix metalloproteinase (MMP) 2 and membrane type 1 MMP in the presence of tissue inhibitor of metalloproteinase 2","volume":"279","author":"Karagiannis","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B92","doi-asserted-by":"publisher","first-page":"6850","DOI":"10.1111\/febs.15776","article-title":"A guide to the composition and functions of the extracellular matrix","volume":"288","author":"Karamanos","year":"2021","journal-title":"FEBS J."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1093\/eurheartj\/ehn206","article-title":"Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction","volume":"29","author":"Kasama","year":"2008","journal-title":"Eur. Heart J."},{"key":"B94","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1161\/01.CIR.0000147829.78357.C5","article-title":"Overexpression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarction","volume":"110","author":"Kawakami","year":"2004","journal-title":"Circulation"},{"key":"B95","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s11883-010-0159-7","article-title":"The role of matrix metalloproteinases in atherothrombosis","volume":"13","author":"Ketelhuth","year":"2011","journal-title":"Curr. Atheroscler. Rep."},{"key":"B96","doi-asserted-by":"publisher","first-page":"9949699","DOI":"10.1155\/2021\/9949699","article-title":"MMP inhibitors and dentin bonding: systematic review and meta\u2010analysis","volume":"2021","author":"Kiuru","year":"2021","journal-title":"Int. J. Dent."},{"key":"B97","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00726-010-0689-x","article-title":"Physiology and pathophysiology of matrix metalloproteases","volume":"41","author":"Klein","year":"2011","journal-title":"Amino acids"},{"key":"B98","article-title":"The impact of Interleukin-6 and alpha2-Macroglobulin on the coagulation system","author":"Knopp","year":"2022","journal-title":"Dr. Diss. Diss"},{"key":"B99","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jpba.2017.11.067","article-title":"HPLC\u2013MS\/MS method optimisation for matrix metalloproteinase 3 and matrix metalloproteinase 9 determination in human blood serum using target analysis","volume":"150","author":"Kotnik","year":"2018","journal-title":"J. Pharm. Biomed. Analysis"},{"key":"B100","doi-asserted-by":"publisher","first-page":"6742","DOI":"10.3390\/ijms21186742","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases in extracellular matrix remodeling during left ventricular diastolic dysfunction and heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"21","author":"Krebber","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B101","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.niox.2010.12.002","article-title":"Nitroglycerin alters matrix remodeling proteins in THP-1 human macrophages and plasma metalloproteinase activity in rats","volume":"24","author":"Krishnatry","year":"2011","journal-title":"Nitric Oxide"},{"key":"B102","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s12079-017-0422-6","article-title":"Periostin function in communication with extracellular matrices","volume":"12","author":"Kudo","year":"2018","journal-title":"J. cell Commun. Signal."},{"key":"B103","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.vascn.2010.02.011","article-title":"Matrix metalloproteinase activity assays: importance of zymography","volume":"61","author":"Kupai","year":"2010","journal-title":"J. Pharmacol. Toxicol. methods"},{"key":"B104","doi-asserted-by":"publisher","first-page":"275","DOI":"10.5551\/jat.10.275","article-title":"Role of matrix metalloproteinases in vascular remodeling","volume":"10","author":"Kuzuya","year":"2003","journal-title":"J. Atheroscler. thrombosis"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1161\/ATVBAHA.119.313129","article-title":"Mechanisms of arterial stiffening: from mechanotransduction to epigenetics","volume":"40","author":"Lacolley","year":"2020","journal-title":"Arteriosclerosis, thrombosis, Vasc. Biol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/jth.15647","article-title":"Alpha\u20102\u2010macroglobulin in hemostasis and thrombosis: an underestimated old double\u2010edged sword","volume":"20","author":"Lagrange","year":"2022","journal-title":"J. Thrombosis Haemostasis"},{"key":"B107","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3390\/biom10050717","article-title":"Challenges in matrix metalloproteinases inhibition","volume":"10","author":"Laronha","year":"2020","journal-title":"Biomolecules"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1161\/01.STR.0000129334.05181.b6","article-title":"Doxycycline suppresses cerebral matrix metalloproteinase-9 and angiogenesis induced by focal hyperstimulation of vascular endothelial growth factor in a mouse model","volume":"35","author":"Lee","year":"2004","journal-title":"Stroke"},{"key":"B109","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12906-017-2058-8","article-title":"The flavonoid hesperidin exerts anti-photoaging effect by downregulating matrix metalloproteinase (MMP)-9 expression via mitogen activated protein kinase (MAPK)-dependent signaling pathways","volume":"18","author":"Lee","year":"2018","journal-title":"BMC complementary Altern. Med."},{"key":"B128","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3109\/1354750X.2011.557440","article-title":"Post-translational modifications of the extracellular matrix are key events in cancer progression: opportunities for biochemical marker development","volume":"16","author":"Leeming","year":"2011","journal-title":"Biomarkers"},{"key":"B110","doi-asserted-by":"publisher","first-page":"659282","DOI":"10.1155\/2013\/659282","article-title":"Role of matrix metalloproteinase\u20108 in atherosclerosis","volume":"2013","author":"Lenglet","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"B111","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1681\/ASN.V113574","article-title":"Matrix metalloproteinases in renal development and disease","volume":"11","author":"Lenz","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"B112","first-page":"247","article-title":"Roles of interactions between cells and extracellular matrices for cell migration and matrix remodeling","volume-title":"Multi-scale extracellular matrix mechanics and mechanobiology","author":"Li","year":""},{"key":"B113","doi-asserted-by":"publisher","first-page":"107465","DOI":"10.1016\/j.pharmthera.2019.107465","article-title":"The past, present and future perspectives of matrix metalloproteinase inhibitors","volume":"207","author":"Li","year":"","journal-title":"Pharmacol. & Ther."},{"key":"B114","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/gm424","article-title":"Functional decorations: post-translational modifications and heart disease delineated by targeted proteomics","volume":"5","author":"Liddy","year":"2013","journal-title":"Genome Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1055\/s-2007-990220","article-title":"Inhibition of mammalian collagenase, matrix metalloproteinase-1, by naturally-occurring flavonoids","volume":"73","author":"Lim","year":"2007","journal-title":"Planta medica"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/s0741-5214(03)01022-x","article-title":"Mechanism of inhibition of matrix metalloproteinase-2 expression by doxycycline in human aortic smooth muscle cells","volume":"38","author":"Liu","year":"2003","journal-title":"J. Vasc. Surg."},{"key":"B118","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3390\/biom10060960","article-title":"The many faces of matrix metalloproteinase-7 in kidney diseases","volume":"10","author":"Liu","year":"2020","journal-title":"Biomolecules"},{"key":"B119","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1097\/01.asn.0000092789.67966.5c","article-title":"Angiotensin-converting enzyme inhibition but not angiotensin II receptor blockade regulates matrix metalloproteinase activity in patients with glomerulonephritis","volume":"14","author":"Lods","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1183\/09031936.00146510","article-title":"Series \u201cmatrix metalloproteinases in lung health and disease\u201d: biological role of matrix metalloproteinases: a critical balance","volume":"38","author":"L\u00f6ffek","year":"2011","journal-title":"Eur. Respir. J."},{"key":"B121","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/ajo.12399","article-title":"SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014","volume":"55","author":"Lowe","year":"2015","journal-title":"Aust. N. Z. J. Obstetrics Gynaecol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.3390\/ijms23031806","article-title":"The role of matrix metalloproteinases (MMP-8, MMP-9, MMP-13) in periodontal and peri-implant pathological processes","volume":"23","author":"Luchian","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B123","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.3390\/ijms21082840","article-title":"Expression of matrix metalloproteinases and their inhibitors in endometrium: high levels in endometriotic lesions","volume":"21","author":"Luddi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B124","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/tpj.2014.26","article-title":"Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy","volume":"14","author":"Luizon","year":"2014","journal-title":"pharmacogenomics J."},{"key":"B125","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1046\/j.1432-0436.2002.700909.x","article-title":"Matrix metalloproteinases in tumor\u2013host cell communication","volume":"70","author":"Lynch","year":"2002","journal-title":"Differ. Rev."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00424-014-1463-9","article-title":"Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling","volume":"466","author":"Ma","year":"2014","journal-title":"Pfl\u00fcgers Archiv-European J. Physiology"},{"key":"B127","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1007\/s12265-012-9398-z","article-title":"Extracellular matrix and fibroblast communication following myocardial infarction","volume":"5","author":"Ma","year":"2012","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"B129","first-page":"3077","article-title":"Post-translational modification-dependent activity of matrix metalloproteinases","volume-title":"Int. J. Mol. Sci.","author":"Madzharova","year":"2019"},{"key":"B130","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.preghy.2014.01.003","article-title":"Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy","volume":"4","author":"Magee","year":"2014","journal-title":"Pregnancy Hypertens. An Int. J. Women's Cardiovasc. Health"},{"key":"B131","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/03008200802143190","article-title":"Extracellular matrix: a matter of life and death","volume":"49","author":"Marastoni","year":"2008","journal-title":"Connect. tissue Res."},{"key":"B132","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/HJH.0b013e32834d249a","article-title":"Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: a systematic review and meta-analysis","volume":"30","author":"Marchesi","year":"2012","journal-title":"J. Hypertens."},{"key":"B133","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1055\/s-0038-1629902","article-title":"\u03b12-macroglobulin is a significant in vivo inhibitor of activated protein C and low APC: \u03b12M levels are associated with venous thromboembolism","volume":"118","author":"Martos","year":"2018","journal-title":"Thrombosis haemostasis"},{"key":"B134","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jnutbio.2005.05.014","article-title":"Inhibition of matrix metalloproteinase activity in DU145 human prostate cancer cells by flavonoids from lowbush blueberry (Vaccinium angustifolium): possible roles for protein kinase C and mitogen-activated protein-kinase-mediated events","volume":"17","author":"Matchett","year":"2006","journal-title":"J. Nutr. Biochem."},{"key":"B135","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2174\/1389450111314030005","article-title":"Inhibition of matrix metalloproteinases (MMPs) as a potential strategy to ameliorate hypertension-induced cardiovascular alterations","volume":"14","author":"M Castro","year":"2013","journal-title":"Curr. drug targets"},{"key":"B136","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/j.1471-0528.2004.00223.x","article-title":"The role of matrix metalloproteinases in vascular function: implications for normal pregnancy and pre\u2010eclampsia","volume":"111","author":"Merchant","year":"2004","journal-title":"BJOG An Int. J. Obstetrics & Gynaecol."},{"key":"B137","article-title":"Etiology and pathophysiology of hypertensive disease","volume-title":"Hypertensive disease in pregnancy","author":"Mistry","year":"2013"},{"key":"B138","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2147\/mnm.s65143","article-title":"Matrix metalloproteinase protein inhibitors: highlighting a new beginning for metalloproteinases in medicine","author":"Mohan","year":"2016","journal-title":"Metalloproteinases Med."},{"key":"B139","doi-asserted-by":"publisher","first-page":"112260","DOI":"10.1016\/j.ejmech.2020.112260","article-title":"Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: a minireview","volume":"194","author":"Mondal","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"B140","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41598-019-56856-3","article-title":"MMP-10 is increased in early stage diabetic kidney disease and can be reduced by renin-angiotensin system blockade","volume":"10","author":"Mora-Guti\u00e9rrez","year":"2020","journal-title":"Sci. Rep."},{"key":"B141","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1046\/j.1523-1755.2003.00315.x","article-title":"Circulating level of alpha2-macroglobulin-beta2-microglobulin complex in hemodialysis patients","volume":"64","author":"Motomiya","year":"2003","journal-title":"Kidney Int."},{"key":"B142","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/ijms17070797","article-title":"Role of the renin-angiotensin-aldosterone system beyond blood pressure regulation: molecular and cellular mechanisms involved in end-organ damage during arterial hypertension","volume":"17","author":"Mu\u00f1oz-Durango","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3390\/cells9051151","article-title":"Functional roles of matrix metalloproteinases and their inhibitors in melanoma","volume":"9","author":"Napoli","year":"2020","journal-title":"Cells"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-020-01107-4","article-title":"Multiple gestations and hypertensive disorders of pregnancy: what do we know?","volume":"23","author":"Narang","year":"2021","journal-title":"Curr. Hypertens. Rep."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.2174\/0929867325666171205143441","article-title":"Role of matrix metalloproteinases in degenerative kidney disorders","volume":"25","author":"Narula","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"B146","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.2174\/138161207781039706","article-title":"Matrix metalloproteinase inhibitors: new challenges in the era of post broad-spectrum inhibitors","volume":"13","author":"Nuti","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"B147","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5603\/FHC.a2016.0022","article-title":"Doxycycline down-regulates matrix metalloproteinase expression and inhibits NF-\u03baB signaling in LPS-induced PC3 cells","volume":"54","author":"Ogut","year":"2016","journal-title":"Folia Histochem. Cytobiol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1016\/j.ajog.2005.10.275","article-title":"The effect of 2-macroglobulin on VEGF-induced endothelin-1 upregulation in human umbilical vein endothelial cells","volume":"193","author":"Oh","year":"2005","journal-title":"Am. J. Obstetrics & Gynecol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/j.1540-8167.2011.02059.x","article-title":"Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase\u20102 as a predictor of atrial fibrillation recurrence","volume":"22","author":"Okumura","year":"2011","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"B116","first-page":"92","article-title":"Matrix metalloproteinase-9-dependent mechanisms of reduced contractility and increased stiffness in the aging heart","volume-title":"Proteomics Clin Appl.","author":"Padmanabhan Iyer","year":"2016"},{"key":"B150","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.yexmp.2012.01.008","article-title":"Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy","volume":"92","author":"Palei","year":"","journal-title":"Exp. Mol. pathology"},{"key":"B151","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1742-7843.2012.00905.x","article-title":"Effects of matrix metalloproteinase (MMP)\u20102 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy","volume":"111","author":"Palei","year":"","journal-title":"Basic & Clin. Pharmacol. & Toxicol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.clinbiochem.2008.04.015","article-title":"Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension","volume":"41","author":"Palei","year":"2008","journal-title":"Clin. Biochem."},{"key":"B153","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/apha.12106","article-title":"Pathophysiology of hypertension in pre\u2010eclampsia: a lesson in integrative physiology","volume":"208","author":"Palei","year":"2013","journal-title":"Acta physiol."},{"key":"B154","first-page":"76","article-title":"Matrix metalloproteinases and cardiovascular diseases","volume":"13","author":"Papazafiropoulou","year":"2009","journal-title":"Hippokratia"},{"key":"B155","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11010-013-1612-z","article-title":"Suppression of atrial natriuretic peptide\/natriuretic peptide receptor-A-mediated signaling upregulates angiotensin-II-induced collagen synthesis in adult cardiac fibroblasts","volume":"378","author":"Parthasarathy","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"B156","doi-asserted-by":"publisher","first-page":"5581570","DOI":"10.1155\/2021\/5581570","article-title":"The role of oxidative stress in hypertensive disorders of pregnancy (preeclampsia, gestational hypertension) and metabolic disorder of pregnancy (gestational diabetes mellitus)","volume":"2021","author":"Phoswa","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"B157","doi-asserted-by":"publisher","first-page":"H87","DOI":"10.1152\/ajpheart.01206.2010","article-title":"Doxycycline, a matrix metalloprotease inhibitor, reduces vascular remodeling and damage after cerebral ischemia in stroke-prone spontaneously hypertensive rats","volume":"301","author":"Pires","year":"2011","journal-title":"Am. J. Physiology-Heart Circulatory Physiology"},{"key":"B158","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3390\/biom11040585","article-title":"Matrix metalloproteinases and arterial hypertension: role of oxidative stress and nitric oxide in vascular functional and structural alterations","volume":"11","author":"Prado","year":"2021","journal-title":"Biomolecules"},{"key":"B159","doi-asserted-by":"publisher","first-page":"115412","DOI":"10.1016\/j.bcp.2023.115412","article-title":"Epigenetic modifications and fetal programming: molecular mechanisms to control hypertension inheritance","volume":"208","author":"Priviero","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/biom10010154","article-title":"The association of matrix metalloproteinases with chronic kidney disease and peripheral vascular disease: a light at the end of the tunnel?","volume":"10","author":"Provenzano","year":"2020","journal-title":"Biomolecules"},{"key":"B161","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/jcp.10142","article-title":"New insights into the role of extracellular matrix during tumor onset and progression","volume":"192","author":"Pupa","year":"2002","journal-title":"J. Cell. physiology"},{"key":"B162","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1097\/HJH.0b013e3283649b33","article-title":"Angiotensin-II induced hypertension and renovascular remodelling in tissue inhibitor of metalloproteinase 2 knockout mice","volume":"31","author":"Pushpakumar","year":"2013","journal-title":"J. Hypertens."},{"key":"B163","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/bs.pmbts.2017.02.002","article-title":"The role matrix metalloproteinases in the production of aortic aneurysm","volume":"147","author":"Rabkin","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"B164","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.bcp.2007.07.004","article-title":"Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease","volume":"75","author":"Raffetto","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s003950170074","article-title":"Cardiac isoform of \u03b1-2 macroglobin, a novel serum protein, may induce cardiac hypertrophy in rats","volume":"96","author":"Rajamanickam","year":"2001","journal-title":"Basic Res. Cardiol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1159\/000343304","article-title":"Catecholamines can induce pulmonary remodeling in rats","volume":"30","author":"Rassler","year":"2012","journal-title":"Cell. Physiology Biochem."},{"key":"B167","doi-asserted-by":"publisher","first-page":"5770","DOI":"10.4049\/jimmunol.0900127","article-title":"Alpha 2-macroglobulin capture allows detection of mast cell chymase in serum and creates a reservoir of angiotensin II-generating activity","volume":"182","author":"Raymond","year":"2009","journal-title":"J. Immunol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/hr.2010.264","article-title":"The role of oxidative stress in the pathophysiology of hypertension","volume":"34","author":"Rodrigo","year":"2011","journal-title":"Hypertens. Res."},{"key":"B169","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/cosmetics7030071","article-title":"Natural flavones and flavonols: relationships among antioxidant activity, glycation, and metalloproteinase inhibition","volume":"7","author":"Ronsisvalle","year":"2020","journal-title":"Cosmetics"},{"key":"B170","doi-asserted-by":"publisher","first-page":"R1258","DOI":"10.1152\/ajpregu.90864.2008","article-title":"The pathophysiology of hypertension in systemic lupus erythematosus","volume":"296","author":"Ryan","year":"2009","journal-title":"Am. J. physiology. Regul. Integr. Comp. physiology"},{"key":"B171","doi-asserted-by":"publisher","first-page":"6505383","DOI":"10.1155\/2016\/6505383","article-title":"Polyphenols from Chilean propolis and pinocembrin reduce MMP\u20109 gene expression and activity in activated macrophages","volume":"2016","author":"Saavedra","year":"2016","journal-title":"BioMed Res. Int."},{"key":"B172","doi-asserted-by":"publisher","first-page":"109487","DOI":"10.1016\/j.cellsig.2019.109487","article-title":"Extracellular matrix-cell interactions: focus on therapeutic applications","volume":"66","author":"Sainio","year":"2020","journal-title":"Cell. Signal."},{"key":"B173","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1161\/01.CIR.0000125741.88712.77","article-title":"Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of angiotensin-converting enzyme inhibitor","volume":"109","author":"Sakata","year":"2004","journal-title":"Circulation"},{"key":"B174","first-page":"99","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases in chronic kidney disease and acute kidney injury: a systematic review of the literature","volume":"22","author":"Sampieri","year":"2018","journal-title":"Hippokratia"},{"key":"B175","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cbi.2015.07.014","article-title":"Flavonoids suppress human glioblastoma cell growth by inhibiting cell metabolism, migration, and by regulating extracellular matrix proteins and metalloproteinases expression","volume":"242","author":"Santos","year":"2015","journal-title":"Chemico-biological Interact."},{"key":"B176","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ejphar.2010.07.001","article-title":"Inhibitory effect of quercetin on matrix metalloproteinase 9 activity Molecular mechanism and structure\u2013activity relationship of the flavonoid\u2013enzyme interaction","volume":"644","author":"Saragusti","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3390\/biom11040578","article-title":"The emerging role of epigenetic mechanisms in the causation of aberrant MMP activity during human pathologies and the use of medicinal drugs","volume":"11","author":"Sarker","year":"2021","journal-title":"Biomolecules"},{"key":"B178","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1002\/pmic.200601022","article-title":"Valsartan reverses post\u2010translational modifications of the \u03b4\u2010subunit of ATP synthase during in vivo canine reperfused myocardial infarction","volume":"7","author":"Sawicki","year":"2007","journal-title":"Proteomics"},{"key":"B179","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1080\/14779072.2018.1540301","article-title":"Pathophysiology of essential hypertension: an update","volume":"16","author":"Saxena","year":"2018","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"B180","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.vph.2018.02.009","article-title":"Epigenetic modulation of vascular diseases: assessing the evidence and exploring the opportunities","volume":"107","author":"Schiattarella","year":"2018","journal-title":"Vasc. Pharmacol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.yexcr.2013.03.016","article-title":"The selective role of ECM components on cell adhesion, morphology, proliferation and communication in vitro","volume":"319","author":"Schlie-Wolter","year":"2013","journal-title":"Exp. cell Res."},{"key":"B182","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.joca.2018.09.001","article-title":"CRISPR-Cas9 targeting of MMP13 in human chondrocytes leads to significantly reduced levels of the metalloproteinase and enhanced type II collagen accumulation","volume":"27","author":"Seidl","year":"2019","journal-title":"Osteoarthr. Cartil."},{"key":"B183","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-9-269","article-title":"Catecholamine up-regulates MMP-7 expression by activating AP-1 and STAT3 in gastric cancer","volume":"9","author":"Shi","year":"2010","journal-title":"Mol. cancer"},{"key":"B184","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1258\/vasc.2011.201202","article-title":"Matrix metalloproteinases in vascular physiology and disease","volume":"20","author":"Siefert","year":"2012","journal-title":"Vascular"},{"key":"B185","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/BF02977608","article-title":"Structure activity relationship of antioxidative property of flavonoids and inhibitory effect on matrix metalloproteinase activity in UVA-irradiated human dermal fibroblast","volume":"30","author":"Sim","year":"2007","journal-title":"Archives pharmacal Res."},{"key":"B186","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.jacc.2004.02.037","article-title":"Clinical classification of pulmonary hypertension","volume":"43","author":"Simonneau","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"B187","doi-asserted-by":"publisher","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1089\/scd.2012.0299","article-title":"The matrix metalloproteinase inhibitor marimastat promotes neural progenitor cell differentiation into neurons by gelatinase-independent TIMP-2-dependent mechanisms","volume":"22","author":"Sinno","year":"2013","journal-title":"Stem cells Dev."},{"key":"B190","first-page":"327","article-title":"Matrix metalloproteinases\u2013biochemical characteristics and clinical value determination in breast cancer patients","volume":"9","author":"\u015aliwowska","year":"2005","journal-title":"Contemp. Oncology\/Wsp\u00f3\u0142czesna Onkol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.clinbiochem.2005.02.010","article-title":"Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities","volume":"38","author":"Souza-Tarla","year":"2005","journal-title":"Clin. Biochem."},{"key":"B192","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1096\/fj.03-0454fje","article-title":"Catecholamines potentiate LPS\u2010induced expression of MMP\u20101 and MMP\u20109 in human monocytes and in the human monocytic cell line U937: possible implications for peri\u2010operative plaque instability","volume":"18","author":"Speidl","year":"2004","journal-title":"FASEB J."},{"key":"B193","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bcp.2014.04.011","article-title":"Targeting matrix metalloproteinases in heart disease: lessons from endogenous inhibitors","volume":"90","author":"Spinale","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1074\/jbc.M111.314609","article-title":"Biochemical analysis of matrix metalloproteinase activation of chemokines CCL15 and CCL23 and increased glycosaminoglycan binding of CCL16","volume":"287","author":"Starr","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B195","doi-asserted-by":"publisher","first-page":"6447","DOI":"10.1021\/jf070621c","article-title":"Procyanidin oligomers from Japanese quince (Chaenomeles japonica) fruit inhibit activity of MMP-2 and MMP-9 metalloproteinases","volume":"55","author":"Strek","year":"2007","journal-title":"J. Agric. food Chem."},{"key":"B196","doi-asserted-by":"publisher","first-page":"116563","DOI":"10.1016\/j.lfs.2019.116563","article-title":"Renin-angiotensin system activation and imbalance of matrix metalloproteinase-9\/tissue inhibitor of matrix metalloproteinase-1 in cold-induced stroke","volume":"231","author":"Su","year":"2019","journal-title":"Life Sci."},{"key":"B197","doi-asserted-by":"publisher","first-page":"1453901","DOI":"10.3389\/fcell.2024.1453901","article-title":"Role of post-translational modifications of Sp1 in cardiovascular diseases","volume":"12","author":"Sun","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"B198","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ogc.2018.01.012","article-title":"Hypertensive disorders in pregnancy","volume":"45","author":"Sutton","year":"2018","journal-title":"Obstetrics Gynecol. Clin."},{"key":"B199","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/jcdd9080276","article-title":"Cardiac complications of hypertensive emergency: classification, diagnosis and management challenges","volume":"9","author":"Talle","year":"2022","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"B200","doi-asserted-by":"publisher","first-page":"F1351","DOI":"10.1152\/ajprenal.00037.2012","article-title":"Matrix metalloproteinases in kidney homeostasis and diseases","volume":"302","author":"Tan","year":"2012","journal-title":"Am. J. physiology-renal physiology"},{"key":"B201","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12890-020-1103-4","article-title":"Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort","volume":"20","author":"Todd","year":"2020","journal-title":"BMC Pulm. Med."},{"key":"B202","doi-asserted-by":"publisher","first-page":"17554","DOI":"10.1074\/jbc.M313041200","article-title":"Alpha2-macroglobulin is a novel substrate for ADAMTS-4 and ADAMTS-5 and represents an endogenous inhibitor of these enzymes","volume":"279","author":"Tortorella","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B203","first-page":"79","article-title":"Current best practice in the management of hypertensive disorders in pregnancy","volume-title":"Integr. Blood Press. Control","author":"Townsend","year":"2016"},{"key":"B204","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.preghy.2014.02.001","article-title":"The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP","volume":"4","author":"Tranquilli","year":"2014","journal-title":"An Int. J. Women's Cardiovasc. Health"},{"key":"B205","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.trsl.2019.02.007","article-title":"B-type natriuretic peptide enhances fibrotic effects via matrix metalloproteinase-2 expression in the mouse atrium in vivo and in human atrial myofibroblasts in vitro","volume":"208","author":"Tsai","year":"2019","journal-title":"Transl. Res."},{"key":"B206","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matbio.2019.11.005","article-title":"The role of extracellular matrix in biomechanics and its impact on bioengineering of cells and 3D tissues","volume":"85","author":"Urbanczyk","year":"2020","journal-title":"Matrix Biol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.yjmcc.2016.01.011","article-title":"Extracellular matrix-mediated cellular communication in the heart","volume":"91","author":"Valiente-Alandi","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B208","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3109\/10409238.2013.770819","article-title":"Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade","volume":"48","author":"Vandooren","year":"2013","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"B209","doi-asserted-by":"publisher","first-page":"37585","DOI":"10.1074\/jbc.M611500200","article-title":"A biochemical model of matrix metalloproteinase 9 activation and inhibition","volume":"282","author":"Vempati","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B210","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1136\/heartjnl-2015-307461","article-title":"The pathophysiology of hypertensive acute heart failure","volume":"101","author":"Viau","year":"2015","journal-title":"Heart"},{"key":"B211","volume-title":"Mapping and CRISPR\/Cas9 gene editing for identifying novel genomic factors influencing blood pressure","author":"Waghulde","year":"2016"},{"key":"B212","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.3390\/ijms19103028","article-title":"Role of extracellular matrix in development and cancer progression","volume":"19","author":"Walker","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B213","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1161\/01.ATV.0000151373.33830.41","article-title":"Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness","volume":"25","author":"Wallace","year":"2005","journal-title":"Arteriosclerosis, thrombosis, Vasc. Biol."},{"key":"B214","doi-asserted-by":"publisher","first-page":"dev175596","DOI":"10.1242\/dev.175596","article-title":"The extracellular matrix in development","volume":"147","author":"Walma","year":"2020","journal-title":"Development"},{"key":"B215","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1161\/01.HYP.0000074905.22908.A6","article-title":"Effects of pressure overload on extracellular matrix expression in the heart of the atrial natriuretic peptide\u2013null mouse","volume":"42","author":"Wang","year":"2003","journal-title":"Hypertension"},{"key":"B216","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1161\/HYPERTENSIONAHA.114.03618","article-title":"Matrix metalloproteinases promote arterial remodeling in aging, hypertension, and atherosclerosis","volume":"65","author":"Wang","year":"2015","journal-title":"Hypertension"},{"key":"B217","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s13238-018-0560-5","article-title":"CRISPR\/Cas9-mediated gene knockout reveals a guardian role of NF-\u03baB\/RelA in maintaining the homeostasis of human vascular cells","volume":"9","author":"Wang","year":"2018","journal-title":"Protein & cell"},{"key":"B218","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/art.38576","article-title":"Identification of \u03b12\u2010macroglobulin as a master inhibitor of cartilage\u2010degrading factors that attenuates the progression of posttraumatic osteoarthritis","volume":"66","author":"Wang","year":"2014","journal-title":"Arthritis & rheumatology"},{"key":"B219","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/bs.apha.2017.08.002","article-title":"Matrix metalloproteinases, vascular remodeling, and vascular disease","volume":"81","author":"Wang","year":"2018","journal-title":"Adv. Pharmacol."},{"key":"B220","doi-asserted-by":"publisher","first-page":"39","DOI":"10.14390\/jsshp.hrp2017-018","article-title":"New definition and classification of \u201chypertensive disorders of pregnancy (HDP)\u201d","volume":"5","author":"Watanabe","year":"2017","journal-title":"Hypertens. Res. Pregnancy"},{"key":"B221","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1161\/CIRCRESAHA.118.313206","article-title":"MMP (Matrix Metalloprotease)-9\u2013producing monocytes enable T cells to invade the vessel wall and cause vasculitis","volume":"123","author":"Watanabe","year":"2018","journal-title":"Circulation Res."},{"key":"B222","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrm3620","article-title":"Role of the extracellular matrix in regulating stem cell fate","volume":"14","author":"Watt","year":"2013","journal-title":"Nat. Rev. Mol. cell Biol."},{"key":"B223","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.phrs.2016.09.002","article-title":"Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension","volume":"113","author":"Weber","year":"2016","journal-title":"Pharmacol. Res."},{"key":"B224","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.emc.2019.01.008","article-title":"Hypertensive disorders of pregnancy","volume":"37","author":"Wilkerson","year":"2019","journal-title":"Emerg. Med. Clin."},{"key":"B225","article-title":"Using the plasma proteome for risk stratifying patients with pulmonary arterial hypertension","author":"Wort","year":"2021"},{"key":"B226","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.amjms.2019.10.014","article-title":"Differential expression of renin-angiotensin system-related components in patients with rheumatoid arthritis and osteoarthritis","volume":"359","author":"Wu","year":"2020","journal-title":"Am. J. Med. Sci."},{"key":"B227","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/pmic.201400366","article-title":"Serum protein S100A9, SOD3, and MMP9 as new diagnostic biomarkers for pulmonary tuberculosis by iTRAQ\u2010coupled two\u2010dimensional LC\u2010MS\/MS","volume":"15","author":"Xu","year":"2015","journal-title":"Proteomics"},{"key":"B228","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1586\/17446651.3.6.699","article-title":"Catecholamines can mediate stress-related effects on tumor progression","volume":"3","author":"Yang","year":"2008","journal-title":"Expert Rev. Endocrinol. & metabolism"},{"key":"B229","doi-asserted-by":"publisher","first-page":"10357","DOI":"10.1158\/0008-5472.CAN-06-2496","article-title":"Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells","volume":"66","author":"Yang","year":"2006","journal-title":"Cancer Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/1470320311423780","article-title":"Angiotensin II induces extracellular matrix metalloproteinase inducer expression via an AT1R dependent pathway in aortic atherosclerotic plaque in apolipoprotein E knockout mice","volume":"13","author":"Yang","year":"2012","journal-title":"J Renin Angiotensin Aldosterone Syst."},{"key":"B230","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1159\/000499876","article-title":"Matrix metalloproteinases in renal diseases: a critical appraisal","volume":"44","author":"Zakiyanov","year":"2019","journal-title":"Kidney Blood Press. Res."},{"key":"B231","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/bs.acc.2021.02.003","article-title":"Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in kidney disease","volume":"105","author":"Zakiyanov","year":"2021","journal-title":"Adv. Clin. Chem."},{"key":"B232","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.yjmcc.2012.07.017","article-title":"Transgenic overexpression of matrix metalloproteinase-9 in macrophages attenuates the inflammatory response and improves left ventricular function post-myocardial infarction","volume":"53","author":"Zamilpa","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B233","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1177\/1535370218824101","article-title":"Pulmonary arterial hypertension in connective tissue disorders: pathophysiology and treatment","volume":"244","author":"Zanatta","year":"2019","journal-title":"Exp. Biol. Med."},{"key":"B234","doi-asserted-by":"publisher","first-page":"A097","DOI":"10.1161\/hyp.70.suppl_1.097","article-title":"Abstract 097: knockout of matrix metalloproteinase 9 protects against hypertension-induced renal disease in hypertensive Dahl S rats","volume":"70","author":"Zhang","year":"2017","journal-title":"Hypertension"},{"key":"B235","doi-asserted-by":"publisher","first-page":"84","DOI":"10.5527\/wjn.v2.i3.84","article-title":"Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases","volume":"2","author":"Zhao","year":"2013","journal-title":"World J. Nephrol."},{"key":"B236","doi-asserted-by":"publisher","first-page":"10705","DOI":"10.1021\/acs.jmedchem.0c00352","article-title":"Matrix metalloproteinases as new targets in Alzheimer\u2019s disease: opportunities and challenges","volume":"63","author":"Zipfel","year":"2020","journal-title":"J. Med. Chem."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1559288\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T10:05:16Z","timestamp":1748253916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1559288\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":236,"alternative-id":["10.3389\/fphar.2025.1559288"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1559288","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"article-number":"1559288"}}